Sofia Bragança

Inês Inocêncio

Bárbara Monteiro

An evolutionary journey across the CLL course

Host

Ana Queirós, PhD, Myeloma Lymphoma Research Group


Venue

Seminar Room

Hugo Rodrigues Gaspar

Inês Pinho

19 March 2026

Ciência di Noz Manera stands for Inclusion in Science and Education

Now in its 5th edition, CNM continues to strengthen connections between schools and research institutions. In Phase I, scientists from the GIMM Foundation and the Champalimaud Foundation introduced the programme to more than 100 8th-grade students at Escola Dr. Azevedo Neves (Damaia, Amadora). Phase II then brought students and teachers into the research environment.

06 March 2026

Champalimaud Foundation and Universidade Católica Portuguesa establish partnership to strengthen biomedical research in Portugal

The agreement establishes a long-term framework for collaboration between the two institutions, creating a model that brings university research closer to one of the country’s most advanced scientific infrastructures while fostering the development of new joint initiatives in biomedicine and interdisciplinary research.

Champalimaud Open Seminar (COpS)

Neural mechanisms for learning and storing knowledge about the world

Leopoldo Petreanu, Cortical Circuits
 

From Clinical Questions to Research Answers: The Immune Microenvironment of Multiple Myeloma and New Immunotherapy Opportunities

Cristina João, Myeloma Lymphoma Research Group
 

04 March 2026

Can the brain sense cancer? Up to $25M awarded to a team including the Champalimaud Foundation to explore a new frontier in oncology

Led by the Francis Crick Institute in the UK, the team brings together clinicians, scientists and patient advocates, with researchers spanning eight institutions across four countries. The award is funded jointly by Cancer Research UK and the National Cancer Institute in the US, two of the world’s largest cancer research funders, through the global Cancer Grand Challenges initiative. It marks the first time this prestigious international award has been granted to a Portuguese institution.

Subscribe to Cancer
Loading
Please wait...